Global Proton Therapy Market 2018-2022 - Product Image

Global Proton Therapy Market 2018-2022

  • ID: 4745549
  • Report
  • Region: Global
  • 116 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Hitachi
  • IBA Worldwide
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems
  • MORE
The incidence of many cancers such as lung cancer, breast cancer, prostate cancer, colorectal cancer, and stomach cancer is increasing globally. The associated risk factors of cancers are also on the rise. A significant proportion of the risk of cancer incidence is attributed to the high body mass index, poor dietary habits lack of physical activity, tobacco use and alcohol consumption. Analysts have predicted that the proton therapy market will register a CAGR of over 9% by 2022.

Market Overview

Advantages of proton therapy over standard radiation therapies

Protons can be charged to reach the exact depth where a tumor is located, then stop its further growth. Therefore, proton beams minimize exposure to the nearby healthy tissue surrounding the tumor.

High cost of proton bean therapy and lack of insurance coverage

The high capital costs of proton therapy facilities are restricting their adoption worldwide.

For the detailed list of factors that will drive and challenge the growth of the proton therapy market during the 2018-2022, view this report.

Competitive Landscape

The global proton therapy market is highly concentrated and the market being in a growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Hitachi
  • IBA Worldwide
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 05: MARKET SIZING
  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
  • Segmentation by product
  • Comparison by product
  • Equipment
  • Services
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
  • Geographical segmentation
  • Regional comparison
  • Proton therapy market in Americas
  • Proton therapy market in EMEA
  • Proton therapy market in APAC
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Technological advances
  • Increasing number of clinical trials for indication expansion
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • IBA Worldwide
  • Hitachi
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems
PART 15: APPENDIX
  • List of abbreviations
List of Exhibits
Exhibit 01: Global radiation oncology market
Exhibit 02: Global radiation oncology market - Segments
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global proton therapy market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global proton therapy market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Global proton therapy market - Market share by product 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global proton therapy market by equipment - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global proton therapy market by equipment - Year-over-year growth 2018-2022 (%)
Exhibit 22: Global proton therapy market by services - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global proton therapy market by services - Year-over-year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Global proton therapy market - Market share by region 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Proton therapy market in Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Proton therapy market in Americas - Year-over-year growth 2018-2022 (%)
Exhibit 30: Top two countries in Americas
Exhibit 31: Proton therapy market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Proton therapy market in EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 33: Top two countries in EMEA
Exhibit 34: Proton therapy market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 35: Proton therapy market in APAC - Year-over-year growth 2018-2022 (%)
Exhibit 36: Top two countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: IBA Worldwide - Overview
Exhibit 44: IBA Worldwide - Business segments
Exhibit 45: IBA Worldwide - Organizational developments
Exhibit 46: IBA Worldwide - Geographic focus
Exhibit 47: IBA Worldwide - Segment focus
Exhibit 48: IBA Worldwide - Key offerings
Exhibit 49: IBA Worldwide - Key customers
Exhibit 50: Hitachi - Overview
Exhibit 51: Hitachi - Business segments
Exhibit 52: Hitachi - Organizational developments
Exhibit 53: Hitachi - Geographic focus
Exhibit 54: Hitachi - Segment focus
Exhibit 55: Hitachi - Key offerings
Exhibit 56: Hitachi - Key customers
Exhibit 57: Mevion Medical Systems - Overview
Exhibit 58: Mevion Medical Systems - Product segments
Exhibit 59: Mevion Medical Systems - Organizational developments
Exhibit 60: Mevion Medical Systems - Key offerings
Exhibit 61: Mevion Medical Systems - Key customers
Exhibit 62: ProTom International - Overview
Exhibit 63: ProTom International - Product segments
Exhibit 64: ProTom International - Organizational developments
Exhibit 65: ProTom International - Key offerings
Exhibit 66: ProTom International - Key customers
Exhibit 67: Sumitomo Corporation - Overview
Exhibit 68: Sumitomo Corporation - Business segments
Exhibit 69: Sumitomo Corporation - Organizational developments
Exhibit 70: Sumitomo Corporation - Geographic focus
Exhibit 71: Sumitomo Corporation - Segment focus
Exhibit 72: Sumitomo Corporation - Key offerings
Exhibit 73: Sumitomo Corporation - Key customers
Exhibit 74: Varian Medical Systems - Overview
Exhibit 75: Varian Medical Systems - Business segments
Exhibit 76: Varian Medical Systems - Organizational developments
Exhibit 77: Varian Medical Systems - Geographic focus
Exhibit 78: Varian Medical Systems - Segment focus
Exhibit 79: Varian Medical Systems - Key offerings
Exhibit 80: Varian Medical Systems - Key customers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Hitachi
  • IBA Worldwide
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems
  • MORE
Global Proton Therapy Market 2018-2022

The analyst recognizes the following companies as the key players in the global proton therapy market: IBA Worldwide, Hitachi, Mevion Medical Systems, ProTom International, Sumitomo Corporation, Varian Medical Systems.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the recent technologies advances that is gaining significant interest the introduction of PBS.”

According to the report, one of the major drivers for this market is the advantages of proton therapy over standard radiation therapies.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of proton beam therapy and lack of insurance coverage.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • IBA Worldwide
  • Hitachi
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4745549
Adroll
adroll